GlaxoSmithKline Pharmaceuticals Limited: Detailed financials

Line items extracted directly from the company's exchange-filed XBRL. Click + to expand subtotals. Click any row to chart it. Monetary values are in ₹ crore.

Company financials

Particulars	Dec-24	Mar-25	Jun-25	Sep-25	Dec-25	Mar-26	Jun-26	Sep-26
	949	974	805	980	1,041	995	938	1,184
	35	41	44	34	32	36	44	73
	676	656	570	662	691	658	660	797
	97	115	128	115	80	113	73	129
	164	291	232	233	217	228	379	279
	97	−55	−72	8	67	3	−124	37
	125	153	153	138	152	165	159	170
	0.09	0.58	0.42	0.51	1	0.61	0.97	0.49
	19	15	16	17	20	13	16	15
	174	136	114	151	154	136	156	167
	327	374	295	372	421	387	339	475
	308	359	279	355	401	374	323	460
	—	—	—	3	18	—	—	—
	308	359	279	354	400	373	322	459
	78	96	74	97	104	95	85	123
	230	263	205	257	296	278	237	336
Financial ratios
	34.44%	38.37%	36.63%	37.96%	40.47%	38.87%	36.15%	40.12%
	24.21%	26.98%	25.46%	26.28%	28.39%	27.92%	25.27%	28.38%
	13.57	15.52	12.10	15.07	16.54	16.40	14.00	19.83

Revenue

₹ crore

Select any table row to compare its reported history.

Source: official NSE or BSE financial-result filings & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Derived margins, subtotals, leverage and cash-flow measures use only the displayed filed line items.